文献速递皮肤肿瘤

适用Mohs手术的角质形成细胞癌复发率比较

Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria.
PubMed 文献 · J Am Acad Dermatol · 2017-03-29

本研究基于前瞻性观察队列,回顾性将连续肿瘤按适当使用标准(AUC)分类为适合Mohs显微描记手术(MMS),比较不同治疗后的5年复发率。在适合MMS的1483例肿瘤中,调整后5年复发率MMS为2.9%,切除为5.5%,破坏为4.0%,其他治疗为5.9%;仅比较MMS与切除时风险比为0.6(95%CI 0.3-1.0;AUC识别出MMS复发率低于切除的肿瘤,但绝对差异小。

要点

  • 适合MMS的肿瘤中,MMS的5年复发率低于切除,但绝对差异小。
  • 调整后5年复发率:MMS 2.9%,切除5.5%,破坏4.0%,其他5.9%。

核心结论

  • AUC识别出MMS后复发率低于切除的肿瘤,但绝对复发率差异小。

研究设计与样本

  • 前瞻性观察队列研究,回顾性按AUC将连续肿瘤分类为适合MMS,共1483例。

主要发现

  • 适合MMS肿瘤调整后5年复发率:MMS 2.9%(范围1.4-4.3%),切除5.5%(3.1-7.9%),破坏4.0%(0.6-7.2%),其他治疗5.9%(1.5-10.2%)。

临床怎么用

  • 对于AUC判定适合MMS的角质形成细胞癌,MMS的5年复发率低于切除,但绝对差异小,临床决策需综合考量。

局限性

  • 研究普遍性不确定,缺乏随机化,存在未测量特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of Mohs micrographic surgery (MMS) has increased greatly to treat basal cell and cutaneous squamous cell carcinomas (keratinocyte carcinoma [KC]), and consensus-based Appropriate Use Criteria (AUC) were developed to identify tumors for which MMS is appropriate. OBJECTIVE: We sought to compare recurrence rates after different treatments in tumors judged appropriate for MMS. METHODS: We used data from an observational prospective cohort study and retrospectively categorized consecutive tumors as appropriate for MMS according to the AUC. Among appropriate tumors, we used survival analyses to compare 5-year recurrence rates after treatments. RESULTS: Among tumors appropriate for MMS (N = 1483), adjusted 5-year recurrence rates were 2.9% (range, 1.4-4.3%) after MMS, 5.5% (range, 3.1-7.9%) after excision, 4.0% (range, 0.6-7.2%) after destruction, and 5.9% (range, 1.5-10.2%) after other treatments. In tumors treated only with MMS or excision (the most similar subgroups), the adjusted hazard ratio of 5-year recurrence after MMS was 0.6 (95% confidence interval, 0.3-1.0; P = .06). LIMITATIONS: This study is limited by its uncertain generalizability, lack of randomization, and unmeasured characteristics. CONCLUSION: The AUC identified tumors for which recurrence would be less common after MMS than after excision, but the absolute difference in recurrence rates was small.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Stuart SE, Schoen P, Jin C, et al. Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria. J Am Acad Dermatol. 2017. PMID: 28365039. doi:10.1016/j.jaad.2016.12.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。